In the publication authored by Dr. Zuchra Zakirova and a team of Roskamp researchers, led by Dr.'s Ghaniyah Ait-Ghezala and Fiona Crawford, conclude that these discoveries may lead to potential targets for therapeutic intervention.
The study was funded by the Gulf War Illness Research Program (GWIRP), part of the Congressionally Directed Medical Research Program (CDMRP) funded by Congress under the Defense health program (GW100076).
Dr. Ait-Ghezala has recently been awarded a follow-on research grant to identify treatment strategies, which if successful could then be expedited to human trials (GW160107, "Treatment Strategies in a Mouse Model of Chronic Gulf War Illness").
Another Roskamp researcher, Dr. Laila Abdullah, has begun a related GWIRP-funded study, "Identification of Lipid Biomarkers of Inflammation and Metabolic Disturbances in GWI" (GW150056).
Crawford, President and CEO of the Roskamp Institute, serves on the VA Research Advisory Committee on Gulf War Veterans' Illnesses (RAC).
-Anthony Hardie, 91outcomes.com
SOURCE: PubMed, by Dr.'s Zuchra Zakirova, Fiona Crawford, Ghaniyah Ait-Ghezala, et al (Roskamp Institute), published in Proteomics Clinical Applications, March 28, 2107 (ePub ahead of print)